VERA
NASDAQ
$36.99
Vera Therapeutics Inc - Class A (VERA)
Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $81.79 (+121.11%)
Market Cap
$3.04B
FCF 5Y CAGR
+51.60%
Free Cash Flow Yield
-9.67%
Beta (5Y)
1.22
Price Chart
Valuation
Market Cap$3.04B
P/B6.20
Profitability
EBITDA-$383M
EPS-$4.96
Financial Health
Debt-to-Equity15%
Free Cash Flow Yield-9.67%
Growth & Risk
FCF 5Y CAGR+51.60%
Beta (5Y)1.22
Sharpe Ratio0.98